Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $85.6000 (-0.43%) ($85.3900 - $86.8100) on Mon. Aug. 12, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.04% (three month average) | RSI | 59 | Latest Price | $85.6000(-0.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.9% a day on average for past five trading days. | Weekly Trend | BAX advances 0.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(56%) SPLV(52%) VYM(51%) XLP(51%) DIA(48%) | Factors Impacting BAX price | BAX will decline at least -0.52% in a week (0% probabilities). VIXM(-30%) TLT(-19%) VXX(-12%) IFRA(-10%) TIP(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.52% (StdDev 1.04%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
5 Day Moving Average | $84.91(0.81%) | 10 Day Moving Average | $84.65(1.12%) | 20 Day Moving Average | $84.22(1.64%) | To recent high | -0.6% | To recent low | 16.6% | Market Cap | $43.672b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |